Medtronic receives FDA approval for CGMS iPro Recorder
Medtronic Inc. has received FDA approval for its CGMS iPro Recorder, a new physician use continuous glucose monitoring system. The CGMS iPro Recorder records the glucose pattern in a patient, who is advised to wear it for three days. The data is then reviewed by physicians to uncover glucose patterns in the patient and optimize therapy. The device is reimbursable by Medicare.
- Medtronic receives FDA approval for RestoreULTRA
- Medtronic, Inc launches Discyphor Direct™ Catheter System
- A win for medical device makers
- Ranbaxy receives provisional FDA nod for generic Nexium
